Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irsogladine Maleate Tablets

Approval Number

国药准字H10980048

Company山东齐鲁制药有限公司

Registration Date

May 11, 2024

Drug Information

Generic Name

马来酸伊索拉定片

Trade Name

恒至

Brand Name

恒至

Dosage Form

片剂

Strength

2mg

Drug Type

化学药品

Registration Date

May 11, 2024

Company Information

Applicant Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区新泺大街317号

Manufacturing Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区新泺大街317号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

马来酸伊索拉定片 - NMPA 批准文号 | MedPath